Incyte Investors
Incyte is a prominent venture capital fund established in 1991 and located in Wilmington, Delaware, United States The firm specializes in investing in innovative biotechnology and pharmaceutical companies, with a focus on advancing novel therapeutic solutions Incyte has a significant investment scale, managing substantial assets that enable it to support early-stage and growth-stage ventures The fund is recognized for its strategic partnerships and commitment to fostering the development of transformative healthcare technologies
Employee Number:
501-1000
Funding Status:
IPO
Headquarters:
USA
Technology:
Cancer
Estimated Revenue:
$500M to $1B
Founded Date:
1991
Investor Type:
Venture Capital Funds
Industry:
FemTech